Podcasts about biontech pfizer

Der Fastnachtsverein Meenzer Drecksäck sieht sich mit seinem möglichen Ende konfrontiert, Impfstoffhersteller Moderna gewinnt Patentklage gegen Biontech und neue Erkenntnisse über den tatverdächtigen Amokfahrer aus Mannheim. Das und mehr heute im Podcast. Alle Hintergründe zu den Nachrichten des Tages finden Sie hier: https://www.allgemeine-zeitung.de/lokales/mainz/stadt-mainz/loesen-sich-die-meenzer-drecksaeck-auf-4439656 https://www.allgemeine-zeitung.de/politik/politik-deutschland/mannheim-amokfahrer-soll-rechtsextreme-vergangenheit-haben-4442259 https://www.allgemeine-zeitung.de/sport/fussball/fussball-bundesliga/transferticker-mainz-05-laesst-doch-noch-einen-profi-gehen-3459026 https://www.allgemeine-zeitung.de/lokales/worms/stadt-worms/empathieloser-taeter-wegen-versuchten-mordes-verurteilt-4443429 https://www.allgemeine-zeitung.de/panorama/aus-aller-welt/corona-impfstoff-moderna-gewinnt-patentklage-gegenbiontech-4443791 Ein Angebot der VRM.

RNA, one of the oldest and most versatile biomolecules, has recently entered the therapeutic arena. While for many observers the success of mRNA vaccines seemed to come out of the blue, its build on the fundament of research that has large gone ignored. Now mRNA therapeutics are enjoying the limelight of great economic success for companies like BioNTech / Pfizer and Moderna, and the awarding of the 2023 Nobel Prize to two mRNA researchers. But with the fame also comes a huge public backlash of anti-vaxxers who fear the perceived novelty of mRNAs. In the 19th episode of We're doomed, we're saved Louise von Stechow and Andreas Horchler talk with their guest, mRNA researcher Lucia Lapazio who has known the field before and after the hype.

News

News

Am 23. November spricht Benjamin Gollme mit dem Waldbesitzer Eberhard Freiherr von Gemmingen-Hornberg über Windkraftanlagen im Wald. Er fürchtet um den Artenschutz und zweifelt an der Sinnhaftigkeit der Pläne. Die deutsche Ampelkoalition steht vor einem Haushaltsloch, die Lage wird von Tag zu Tag dramatischer. Bekommt die Regierung noch einmal die Kurve? Das fragen wir den Historiker und Schriftsteller Dr. Klaus-Rüdiger Mai. Und mit dem theoretischen Physiker Dr. Klaus Retzlaff geht es um Risikosignale bei mRNA-Produkten. Er und ein internationales Forscherteam untersuchen die Produkte von Biontech/Pfizer und Moderna. Er meint: Die Impfung muss sofort gestoppt werden.

Die US-Gesundheitsbehörde hat einen Rückruf des COVID-19-Impfstoffs von BioNTech/Pfizer verweigert, obwohl in diesem eine unerwartete DNA-Sequenz des Simian-Virus 40 gefunden wurde.

O aumento do número de casos de Covid-19 no país já leva a um aumento das hospitalizações, de acordo com o infectologista francês Benjamin Davido, que atua no hospital Raymond Poincaré, em Garches, perto de Paris. Por precaução, o governo francês decidiu antecipar o início da campanha de vacinação, prevista para o dia 17 de outubro, para o próximo dia 2. Taíssa Stivanin, da RFIOs hospitais do país registram há pelo menos duas semanas um aumento de cerca de 30% de pacientes positivos para o vírus Sars-CoV-2 atendidos em pronto-socorro, segundo a agência nacional de saúde pública (Santé Publique France). Segundo a rede francesa SOS Médécins, que atende pacientes em casa, entre 4 e 10 de setembro a alta foi de cerca de 17% de infecções em todas as faixas etárias, e de 58% entre as crianças.No início da campanha de vacinação, o primeiro imunizante disponível para a população será o da BioNTech-Pfizer, a base de RNA mensageiro e eficaz contra a subvariante XBB.1.5, da ômicron. A vacina da Moderna, que utiliza a mesma tecnologia, também já foi aprovada para uso no país, assim como a Novavax, que ainda aguarda uma autorização final para ser comercializada.O infectologista francês Benjamin Davido, que atua no hospital Raymond Poincaré, nos arredores de Paris, vive no dia a dia os efeitos da alta do número de casos de Covid-19. Ele lembra que, atualmente, não há modelização matemática ou monitoramento que indiquem, com precisão, qual é a dimensão da atual onda de casos.Além disso, observa, os franceses simplesmente não se testam mais. “Nas ondas anteriores, as pessoas já chegavam ao hospital com o diagnóstico. Hoje, os pacientes vêm ao pronto-socorro porque passaram mal ou não estão se sentindo bem, têm dor de cabeça ou falta de ar. O diagnóstico é feito no atendimento de emergência.”De acordo com ele, de cada três pacientes que chegam ao pronto-socorro, um será hospitalizado. Para o infectologista, isso é surpreendente, já que a taxa de internação por Covid, desde o início da epidemia, oscila entre 10 e 15%.“A epidemia está acelerando com novas variantes que são mais contagiosas. O risco, se não aceleramos também a campanha de vacinação, é acabar com pacientes em macas nos corredores, e com dificuldade para organizar a hospitalização”, alerta.Medidas de proteção agora são inexistentesSegundo ele, atualmente também há um risco mais elevado de contaminação dentro do hospital, onde as medidas de proteção, como o uso de máscaras, por exemplo, foram deixadas de lado. Com a chegada do inverno no hemisfério norte, outros vírus, como o da gripe e o da bronquiolite, vão se somar ao da Covid-19, o que pode complicar ainda mais a situação nos hospitais.Na França, a cepa predominante é a EG.5.1, que representa pelo menos 35% das contaminações, mas cerca de 1% dos casos envolvem a subvariante BA.2.86, considerada mais "preocupante" pela OMS (Organização Mundial de Saúde). Elas são mais contagiosas e têm capacidade para driblar a imunidade adquirida pela população ao longo do tempo, o que preocupa as autoridades francesas."A Covid-19 não é um resfriado""É necessário parar de banalizar a Covid-19 e de associar casos graves e mortes apenas à população idosa e com comorbidades", frisa o infectologista francês. A ômicron, lembra, foi responsável pela morte de pelo menos 30 mil pessoas no país em 2022.“Infelizmente, todos os dias pessoas morrem depois de terem sido contaminadas. Não é um resfriado”, reitera. “Hoje, as pessoas que chegam ao hospital são idosas e têm outras patologias. Não quero ser dramático, mas a má notícia é que a epidemia sempre começa assim e depois os pacientes são cada vez mais jovens. Quanto mais o vírus circula, terão mais casos graves.”Outro problema é a falta de informação. A população, diz, não sabe da existência de uma vacina atualizada e também não interiorizou o fato de que as doses de reforço, assim como no caso da gripe, devem ser frequentes – entre seis meses e um ano, em função dos riscos."É preciso parar de contar as doses. A vacinação no caso da Covid deve ser feita periodicamente", lembra. Seis meses depois da vacina ou de uma infecção natural, não há mais proteção contra as novas subvariantes. Este é o caso hoje de uma grande parte dos franceses, ressalta, e por isso a dose de reforço é essencial.O desafio agora é lidar com o ceticismo de uma boa parte da população francesa. “De uma certa forma, há urgência. Essas pessoas, nos próximos dias, podem ser contaminadas. Então, neste contexto, avançar a campanha em 15 dias faz muita diferença. Mas esse tempo deve servir para convencer os franceses a se vacinarem.”

Die Zulassungsstudie für den Comirnaty-Impfstoff von BioNTech/Pfizer hat bis zu ihrer Entblindung keinen Unterschied bei den Todesfällen geimpfter oder ungeimpfter Testpersonen ergeben. Das geht aus einer Antwort des Bundesgesundheitsministeriums hervor. Web: https://www.epochtimes.de Probeabo der Epoch Times Wochenzeitung: https://bit.ly/EpochProbeabo Twitter: https://twitter.com/EpochTimesDE YouTube: https://www.youtube.com/channel/UC81ACRSbWNgmnVSK6M1p_Ug Telegram: https://t.me/epochtimesde Gettr: https://gettr.com/user/epochtimesde Facebook: https://www.facebook.com/EpochTimesWelt/ Unseren Podcast finden Sie unter anderem auch hier: iTunes: https://podcasts.apple.com/at/podcast/etdpodcast/id1496589910 Spotify: https://open.spotify.com/show/277zmVduHgYooQyFIxPH97 Unterstützen Sie unabhängigen Journalismus: Per Paypal: http://bit.ly/SpendenEpochTimesDeutsch Per Banküberweisung (Epoch Times Europe GmbH, IBAN: DE 2110 0700 2405 2550 5400, BIC/SWIFT: DEUTDEDBBER, Verwendungszweck: Spenden) Vielen Dank! (c) 2023 Epoch Times

În cadrul ediției de pe 21 martie 2023 a emisiunii #știința360 de pe Radio România Cultural, Dr. Marius Geantă, Președintele Centrului pentru Inovație în Medicină, a comentat ultimele noutăți ale domeniului medical precum și topul săptămânal Esențial Covid-19 de pe Raportuldegardă.ro. Pe fondul unei încrederi deja scăzute în vaccinare, apariția pandemiei de COVID-19 și a vaccinurilor contra SARS-CoV-2 a dat apă la moară antivacciniștilor și grupurilor conspiraționiste. Temerile multor oameni au crescut și pe fondul vaccinării cu seruri obținute în timp record prin tehnologii de ultimă oră, explicațiile autorităților pe acest subiect fiind sumare. Vaccinarea anti-COVID-19 a început în România, la 27 decembrie 2020, prima persoană vaccinată fiind asistenta medicală Mihaela Anghel, de la Institutul Național de Boli Infecțioase „Prof.dr. Matei Balș” din Capitală. Acțiunile au continuat apoi la nivel național. A fost constituit un Comitet național de coordonare a activităților privind vaccinarea împotriva COVID-19 – organism interministerial, fără personalitate juridică, aflat în subordinea Secretariatului General al Guvernului și sub cooordonarea primului ministru. Totodată, a fost lansată o platformă informatică care permitea programarea persoanelor la vaccinare. Prioritate, într-o primă fază, a avut personalul medical și cel social, angajați în instituțiile de îngrijire și apoi, în faza a doua, populația încadrată în grad de risc și lucrătorii din domenii considerate cheie. În etapa a treia, s-a putut imuniza populația generală. Prima tranșă de vaccinuri împotriva COVID-19 a fost compusă din două containere, fiecare a câte 5 cutii conținând în total 9.750 de doze de la compania BioNTech/Pfizer. Vaccinul anti-COVID-19 a fost recomandat mai întâi persoanelor peste 18 ani, după care, din 2021 a fost disponibil și pentru persoanele peste 16 ani. Ultima categorie care a avut acces la un ser dedicat au fost copiii între 5 și 11 ani care au putut fi imunizați cu serul produs de Pfizer/BioNTech începând cu ianuarie 2022. Ultimele date al Platformei ROVaccinare arată că, la nivel național, în februarie 2022, proporția vaccinării a fost de 40,7 la nivelul populației generale, mai mare la oraș – 43-45% și mai mică la țară – 30%. Statistica a plasat România printre țările cu cea mai mică rată de vaccinare din UE, mai puțin decât noi având Bulgaria – 28%, în timp ce media UE a fost de 70%. Mai multe detalii - https://raportuldegarda.ro/vaccinare-pandemie-romania-lectia-covid19/ Mai multe detalii despre subiectele discutate: ▶ https://raportuldegarda.ro/stiri-covid-romania/ ▶ Esențial COVID-19 - https://raportuldegarda.ro/esential-sanatate-publica-retea-supraveghere-genomica-virala-global/ ▶ Planul Francez pentru Medicină Genomică 2025: progrese majore în domeniul bolilor rare și în oncologie prin facilitarea accesului la secvențierea întregului genom în sistemul de sănătate - https://raportuldegarda.ro/plan-francez-medicina-genomica-2025-boli-rare-oncologie-secventiere-genom/ ▶ STUDIU. Testarea comprehensivă genomică pentru cancerul pulmonar non-microcelular avansat, cost-eficientă comparativ cu testarea secvențială a biomarkerilor în Spania - https://raportuldegarda.ro/testare-comprehensiva-genomica-cancer-pulmonar-biomarkeri-spania/

Die Genehmigung des mRNA-Impfstoffs von Biontech/Pfizer erfolgte möglicherweise aufgrund von falschen Unterlagen. An den Daten der entscheidenden Phase-3-Studie gibt es immer mehr Zweifel. Pfizer weicht den Vorwürfen aus und verweigert sich einer Nachprüfung. Als der Patient mit der Nummer 12312982 an die Öffentlichkeit ging, ahnten die Manager beim US-Pharmakonzern Pfizer, dass es jetzt sehr ungemütlich werden könnte. Während der letzten Testphase für die Zulassung des mRNA-Impfstoffs war Nummer 12312982 im September 2020 mit schweren Symptomen ins Krankenhaus eingeliefert worden. Der Patient zog die Reißleine, er stieg aus dem Testverfahren aus...

Die mNRA-Impfstoffe von BioNTech/Pfizer, Moderna und Novavax können zu schweren Herzerkrankungen führen – das räumt sogar das Bundesgesundheitsministerium ein. Trotz deutlich angestiegener Fallzahlen sieht das Ministerium aber keinen Grund, die Impfstoffe vom Markt zu nehmen: Der Nutzen überwiege noch immer das Risiko. Web: https://www.epochtimes.de Probeabo der Epoch Times Wochenzeitung: https://bit.ly/EpochProbeabo Twitter: https://twitter.com/EpochTimesDE YouTube: https://www.youtube.com/channel/UC81ACRSbWNgmnVSK6M1p_Ug Telegram: https://t.me/epochtimesde Gettr: https://gettr.com/user/epochtimesde Facebook: https://www.facebook.com/EpochTimesWelt/ Unseren Podcast finden Sie unter anderem auch hier: iTunes: https://podcasts.apple.com/at/podcast/etdpodcast/id1496589910 Spotify: https://open.spotify.com/show/277zmVduHgYooQyFIxPH97 Unterstützen Sie unabhängigen Journalismus: Per Paypal: http://bit.ly/SpendenEpochTimesDeutsch Per Banküberweisung (Epoch Times Europe GmbH, IBAN: DE 2110 0700 2405 2550 5400, BIC/SWIFT: DEUTDEDBBER, Verwendungszweck: Spenden) Vielen Dank! (c) 2023 Epoch Times

Today we are talking to Drew Weissman. Drew is the Roberts Family Professor in Vaccine Research at Perelman School of Medicine and Director of the Penn Institute for RNA Innovation at the University of Pennsylvania. Drew has spent his career working on RNA biology and vaccine development. He, along with his colleague Katalin Kariko, have been pivotal in the development of mRNA vaccines most notably the COVID-19 vaccines developed by BioNTech/Pfizer and Moderna. Drew received his MD/PhD from Boston University in 1987, following which he did a residency at Beth Israel and followship at the NIH under Anthony Fauci. He has received numerous awards including the Lasker-DeBakey Clinical Medical Research Award and Rosenstiel Award.Today we discuss Drew's career trajectory, mRNA biology and vaccine development.

Vertragliche Verpflichtungen zwischen der Bundesregierung und Biontech/Pfizer bedeutet weiteres Milliardengeschäft für den Vakzinhersteller. Derzeit lassen sich pro Tag etwa 6.000 Menschen impfen. Web: https://www.epochtimes.de Probeabo der Epoch Times Wochenzeitung: https://bit.ly/EpochProbeabo Twitter: https://twitter.com/EpochTimesDE YouTube: https://www.youtube.com/channel/UC81ACRSbWNgmnVSK6M1p_Ug Telegram: https://t.me/epochtimesde Gettr: https://gettr.com/user/epochtimesde Facebook: https://www.facebook.com/EpochTimesWelt/ Unseren Podcast finden Sie unter anderem auch hier: iTunes: https://podcasts.apple.com/at/podcast/etdpodcast/id1496589910 Spotify: https://open.spotify.com/show/277zmVduHgYooQyFIxPH97 Unterstützen Sie unabhängigen Journalismus: Per Paypal: http://bit.ly/SpendenEpochTimesDeutsch Per Banküberweisung (Epoch Times Europe GmbH, IBAN: DE 2110 0700 2405 2550 5400, BIC/SWIFT: DEUTDEDBBER, Verwendungszweck: Spenden) Vielen Dank! (c) 2022 Epoch Times

Pfizer CEO Albert Bourla has bailed on an appointment to testify before the European Parliament's special committee, where he was expected to face tough questions over secretive vaccine deals, Politico reports. Albert Bourla, the Pfizer chief executive, during a visit last week, at a Pfizer factory in Belgium.Credit…Pool photo by John Thys Bourla was scheduled to appear before the panel on Oct. 10, alongside key officials involved in the EUs vaccine procurement process, in order to discuss how to respond to future pandemics. According to the report, “Other pharmaceutical executives have addressed the committee, including the CEO of Moderna and senior officials from AstraZeneca and Sanofi.” Bourla? Not so much. The committee's chair, Belgian MEP Kathleen Van Brempt, told POLITICO she “deeply regrets” the decision taken by Pfizer.After a visit to BioNTech's headquarters last week, Van Brempt had said in a written statement that she looked forward to discussions “with other CEOs” including “Mr. Albert Bourla, the CEO of Pfizer” on October 10. -Politico In early September, an audit repirt into the EU's vaccine procurement strategy raised questions over Bourla's relationship with European Commission President Ursula von der Leyen before they struck a multibillion-euro vaccine deal. The report, by the European Court of Auditors, found that von der Leyen had been directly involved in preliminary negotiations for the EU's biggest vaccine contract, for up to 1.8 billion doses of the BioNTech/Pfizer vaccine, which was concluded in May 2021. This was a departure from the negotiating procedure followed with other contracts, where a joint negotiating team made up of officials from the Commission and member countries conducted exploratory talks. -Politico In April, von der Leyen admitted that she had been texting with Bourla for a month straight while they were negotiating the massive contract. Two months later, the texts disappeared, triggering accusations of maladministration by the EU's ombudsman, Emily O'Reilly,” Reuters reported at the time. Ursula von der Leyen, the president of the European Commission, in Brussels, on Sunday.Credit…Ksenia Kuleshova for The New York Times Bourla and von der Leyen's cozy relationship was noted last year by the NYT, which Bourla told they had “developed a deep trust, because we got into deep discussions.” “She knew details about the variants, she knew details about everything. So that made the discussion, way more engaged.” And now Bourla won't have to answer questions about it. --- Support this podcast: https://anchor.fm/world-voices/support

Professor Katalin Karikó's research led to the creation of the messenger RNA Covid-19 vaccine, which has saved so many lives and helped curb the impact of the pandemic. She has quite literally changed the world! Ilham sits down with Professor Karikó to talk about her invaluable research; her passion for science; her upbringing in Hungary; women in science, technology, engineering and math (STEM) careers; her advice for young scientists, and much more1:42 - Upbringing in Hungary5:26 - Move to the United States7:43 - Development of the Covid-19 vaccine11:23 - mRNA technology as a potential solution for other diseases13:49 - Receiving the covid-19 vaccine - the results of her work15:19 - Story of resilience and determination amid challenges21:15 - Adjusting to almost overnight fame22:50 - Educating the public24:06 - Championing women scientists24:44 - Role models28:28 - Advice to young scientistsProfessor Katalin Karikó is an adjunct professor at the University of Pennsylvania, where she worked for 24 years before joining BioNTech SE in 2013 as a senior VP. She is also professor at University of Szeged, Hungary from where she received her PhD in biochemistry in 1982. For decades, her research has focused on RNA-mediated mechanisms with the ultimate goal of developing mRNA for protein therapy. She investigated RNA-mediated immune activation and together with Drew Weissman discovered that nucleoside modifications suppress the immunogenicity of RNA, which widened the therapeutic potentials of mRNA. Her patent, co-invented with Drew Weissman, was used to create the FDA-approved covid-19 mRNA vaccines by BioNTech/Pfizer and Moderna. Her groundbreaking contribution was to use chemistry to modify the mRNA so that it wouldn't be rejected by the immune system. In the future, her research could be applied to many other diseases such as cancer, influenza, malaria, tuberculosis, and so much more. Professor Karikó has won numerous awards for her incredible work, including the Solvay Prize.  For additional details about the podcast, show notes, and access to resources mentioned during the show, please visit https://www.solvay.com/podcast

Set dem 12.09.22 ist der auf die Omikron Subvarianten BA.4 und BA.5 angepasste Impfstoff von BioNTech/Pfizer zugelassen. Ab der kommenden Woche werden diese in den deutschen Arztpraxen verimpft werden können. Wer sich impfen lassen sollte wurde in einer Impfempfehlung der STIKO der Robert Koch Institutes am 20.09.22 aufgeführt. In der aktuellen Folge wird diese erläutert und diskutiert.

Drei Angepasste Corona-Impfstoffe von Moderna und Biontech/Pfizer sind jetzt zugelassen. Aber wer kann von einer solchen Booster-Impfung profitieren? Dazu hat die Stiko nun eine Empfehlung angekündigt. Die Kernbotschaft wird sein: Alle Menschen unter 60 Jahren, die dreimal geimpft sind und ein gutes Immunsystem haben, müssen sich nicht impfen lassen. Cornelia Eulitz aus der hr-iNFO-Wissenschaftsredaktion erklärt wieso.

Theme vun haut: Neiste Vaccin vu Biontech/Pfizer, Schoulrentrée, Tunnel Schieburg, Fokus, Reform vu Gemengegesetz, Drauwelies a Sport.

Il primo ottobre entrano in vigore in Germania le nuove misure contro il Covid, i dettagli da Cristina Giordano. Moderna denuncia Biontech/Pfizer per violazione di brevetto sui vaccini, l'intervista a Mathieu Klos, del portale Juve Patent. Doveva portare i vaccini alle popolazioni dei paesi terzi ma per ora è un flop: con Gavino Maiocco dell'università di Firenze parliamo del programma Covax. Von Luciana Caglioti.

Theme vun haut: Neiste Vaccin vu Biontech/Pfizer, Schoulrentrée, Tunnel Schieburg, Fokus, Reform vu Gemengegesetz, Drauwelies a Sport.

Seit heute sind in Europa die auf die Omikron Subvariante BA.1 angepassten Impfstoffe von BioNTech/Pfizer und Modern zugelassen. Ab der kommenden Woche können Sie bestellt werden. Eine STIKO Empfehlung gibt es noch nicht (Stand 02.09.22 15:00 Uhr). Vor 2 Tagen wurden noch dazu in den USA  per Notfallzulassung die Impfstoffe gegen die, heute in Deutschland vorherrschende Omikron Subvarianten BA.5  und BA.4 zugelassen. Es wird erwartet, dass auch die EMA gegen Ende des Monats eine Zulassung aussprechen wird. Was ist also zu tun? Impfen, oder warten? Die aktuelle Folge diskutiert einige Antworten. 

Herzlich Willkommen zur Jura Aktuell Folge vom 29.08.2022 Themen der Sendung: - Geld für profitable Firmen? Regierung bei Gasumlage in Erklärungsnot - Moderna reicht Impfstoff-Patentklagen gegen Biontech/Pfizer ein - Irreführende Werbung für Kindermilch juraaktuellpodcast@gmail.com – Kontakt/Fragen/Feedback Trade Republic Empfehlungslink Melde Dich jetzt mit meinem persönlichen Einladungslink an und erhalte eine Aktie in Höhe von bis zu 200 €: https://ref.trade.re/pv3603cw Scalable Capital EmpfehlungslinkNutze den Link, um dein Broker-Depot oder Vermögensverwaltungs-Portfolio zu eröffnen. Komplett digital, schnell und sicher. https://de.scalable.capital/einladung/bdscpc Spenden Link: https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=Y836YQNZJKWEW&source=url Unterstützung des Podcast durch die Nutzung der folgenden Links: Bürgerliches Gesetzbuch BGB - https://amzn.to/3lRiu51 Strafgesetzbuch StGB - https://amzn.to/2Z79OgU Grundgesetzkommentar mit Einigungsvertrag GG - https://amzn.to/2Z8Dmeh Prime Student 6 Monate kostenlos– https://www.amazon.de/gp/student/signup/info?tag=podcastjonasn-21 Audible Probeabo - https://www.amazon.de/dp/B00NTQ6K7E?tag=podcastjonasn-21

Die Sorgen vor weiteren großen Zinsschritten der FED belasteten vor dem Wochenende den Nasdaq 100. Dieser gab knapp 0,8 Prozent ab. Der Dow Jones ging mit einem kleinen Plus von 0,2 Prozent aus dem Handel.

In den USA ist wieder Druck auf dem Kessel. Die Wall Street rutschte gestern nach verhaltenem Start ab. Vor allem die Technologiewerte gaben deutlich ab. Die Misere dürfte sich heute fortsetzen. Die großen Indizes sind vorbörslich im Minus.

Die US-Arzneimittelbehörde hat den Zugang zu dem Covid-Impfstoff von Johnson & Johnson eingeschränkt. Künftig sollen nur noch Erwachsene den Impfstoff erhalten, die die wirksameren mRNA-Impfstoffe von Biontech/Pfizer oder Moderna nicht erhalten können oder wollen, erklärte die FDA am Donnerstag. Grund für die Änderung der Notzulassung des Impfstoffs sei das erhöhte Risiko schwerer Blutgerinnsel. Web: https://www.epochtimes.de Probeabo der Epoch Times Wochenzeitung: https://bit.ly/EpochProbeabo Twitter: https://twitter.com/EpochTimesDE YouTube: https://www.youtube.com/channel/UC81ACRSbWNgmnVSK6M1p_Ug Telegram: https://t.me/epochtimesde Gettr: https://gettr.com/user/epochtimesde Facebook: https://www.facebook.com/EpochTimesWelt/ Unseren Podcast finden Sie unter anderem auch hier: iTunes: https://podcasts.apple.com/at/podcast/etdpodcast/id1496589910 Spotify: https://open.spotify.com/show/277zmVduHgYooQyFIxPH97 Unterstützen Sie unabhängigen Journalismus: Per Paypal: http://bit.ly/SpendenEpochTimesDeutsch Per Banküberweisung (Epoch Times Europe GmbH, IBAN: DE 2110 0700 2405 2550 5400, BIC/SWIFT: DEUTDEDBBER, Verwendungszweck: Spenden) Vielen Dank! (c) 2022 Epoch Times

"We want to create a world-class ecosystem for biotechnology."Felix Wälder, Project Coordinator BioTech-Hub Mainz Subscribe Here Find all options to subscribe to our newsletter, podcast, YouTube channel or listen to our internet radio station here: https://linktr.ee/startupradio We not only focus on the bio part, but we also see the importance of the tech aspect in developing biotechnology products.Felix Wälder, Project Coordinator BioTech-Hub Mainz Our Sponsor Startupraven The best way to identify investors and cooperation partners for early-stage startups. Sign up for early access here: https://startupraven.com/ We want some of the next big ideas to be developed in Mainz and enable them to grow in Mainz. Felix Wälder, Project Coordinator BioTech-Hub Mainz The City The City of Mainz has a very long history, founded by the Romans on the right side of the river Rhine in the 1st century BC. It is the native city of Johannes Gutenberg, the inventor of the movable type printing press. The city is the capital of the German state of Rhineland Palatine and home to several universities, including the research-heavy Johannes Gutenberg University (JGU). Great brains came to Mainz and gathered around great minds … translating their knowledge in products [the COVID vaccine]Felix Wälder, Project Coordinator BioTech-Hub Mainz The city is also home to a growing biotech cluster including spinoffs of the JGU, especially BioNTech, known as the brains behind the BioNTech Pfizer corona vaccines. The company is a smashing success, to a degree that this company alone increased the German GDP by 0,5% (https://www.reuters.com/article/us-germany-economy-biontech-idUSKBN2FB15A). Note that Germany has the 4th largest GDP in the world. This success fills the coffers of the city with money, which in turn they will invest in turning the city into one of the world's premier biotech and tech hubs. We want startups and investors to come to Mainz, become successful here, and stay here.Felix Wälder, Project Coordinator BioTech-Hub Mainz The Guest Our guest today is Felix Wälder (https://www.linkedin.com/in/felix-w%C3%A4lder-b22a63100/), who works for the City of Mainz's utility holding company ZBM. Felix's studies also took him to the University of North Carolina Wilmington. ZBM provides many services for the city and also takes the lead for the Biotech-Hub Project (https://www.zbm.mainz.de/biotech-mainz/). Felix is the project coordinator for BioTech-Hub Mainz. NOTE: We made a little mistake in the name tag, Felix is not an MD for the City of Mainz, but for the ZBM. We will coordinate within the city and give startups, investors, and interested parties all the answers they need. Felix Wälder, Project Coordinator BioTech-Hub Mainz The New Blog We completely changed our website setup and moved our blog to www.medium.com/startuprad-io, where from now on you can now find all of our blog posts

Avrupa Konseyi Bakanlar Komitesi'nden Osman Kavala kararı: Türkiye AİHM'e havale edildi... İpsala'da en az 12 göçmen donarak yaşamını yitirdi...  Erdoğan: Faiz dayatmalarını etkisiz hale getirdik... Vaka sayıları artıyor, yoğun bakımlar alarm veriyor... BioNTech-Pfizer'dan beş yaş altı çocuklar için aşı başvurusu... Domatesin hal fiyatı yüzde 142,87' arttı... Direnin işçiler kazanıyor: Vardiya durduran Alpin Çorap işçilerine 2500 lira zam... Sanatçı Ceylan Ertem, 5 yıldır yaşadığı tacizi anlattı: "Tedirgin oluyorum. Yoruldum..."

In den USA rückt die Möglichkeit einer Corona-Impfung von Kleinkindern einen Schritt näher. Das deutsche Unternehmen Biontech und sein US-Partner Pfizer haben die Notfallzulassung ihres Impfstoffs für Kinder unter fünf Jahren beantragt. Doch Studien zeigen, dass Eltern von Kleinkindern in den USA wenig Vertrauen in die Sicherheit der Impfstoffe haben. Simon, Doriswww.deutschlandfunk.de, Informationen am MorgenDirekter Link zur Audiodatei

Dode Schandarms in de Palz: Twee Mannslüüd fastnahmen +++ Teihndusende op de Straten gegen Corona-Regeln +++ Verreisen ahn Opfrisch-Sprütt nich mehr so eenfach +++ Däänmark: Kene Corona-Regeln mehr +++ BioNTech/Pfizer stellt Andrag för Corona-Impfmiddel för lütte Kinner +++ Dat Weer

Der Dow Jones notierte gestern im Handelsverlauf rund drei Prozent im Minus. Dann setzte jedoch eine Erholungsbewegung ein. Am Ende gelang es dem amerikanischen Leitindex sogar mit einem Plus von 0,3 Prozent aus dem Handel zu gehen.

»Einblick – Der Podcast«, der Podcast für den tieferen aber knackigen Einblick in die relevanten Ereignisse des Gesundheitswesens der vergangenen Woche vom Gesundheitsmanagement der Berlin-Chemie. Immer freitags um 12 Uhr. In dieser Ausgabe: Wir berichten über die Änderungen bei den COVID-neunzehn-Schutzmaßnahmen sowie der Impfpflicht in Gesundheitseinrichtungen und deren Auswirkungen auf die Arztpraxen. Mit dem Corona-Impfstoff von Biontech / Pfizer erwarb sich der Pharmastandort Deutschland weltweit Renommee – aber auch bei der Entwicklung von Corona-Arzneien möchten deutsche Unternehmen punkten. Wie läuft es mit der Ausstellung von elektronischen Arbeitsunfähigkeitsbescheinigungen e-AU – das möchte die KBV mit einer Umfrage in den Arztpraxen herausfinden. Wir haben den Termin des siebzehnten Kongresses für Gesundheitsnetzwerker verschoben – am sechsten und siebten September laden wir sie nach Berlin ein, um über die Zukunft des Gesundheitswesens zu diskutieren.

Impfstoff-Aktien wie BioNTech, Pfizer, Valneva und Novavax sind aktuell extrem volatil und ein beliebtes Tradingobjekt für Spekulanten und Privatanleger. Gerade in diesem Umfeld ist es deshalb wichtiger denn je, auch fundamental eine treffende Analyse dieser Unternehmen durchzuführen. Unser Gast, der Fondsmanager Dr. med. Markus Manns erläutert seine Sicht auf die aktuelle Corona-Situationen und natürlich auch die neuesten Entwicklungen rund um die einzelnen börsennotierten Unternehmen. ⌚ Timestamps: (0:00) Intro (1:25) Die aktuelle Volatilität bei Impfstoff-Aktien (2:40) Kriterien für den Fair Value einer Impfstoff-Aktie (5:02) Der Einfluss von Omikron auf die Bewertung der Aktien (7:14) Manns' Sichtweise auf die Novavax-Aktie (8:39) Mann's Sichtweise auf die Valneva-Aktie (9:43) Corona-Medikamente und -therapien im Überblick (12:45) Die neuen Pillen gegen Corona von Pfizer und Merck (15:10) Neue Trends bei Covid-19-Medikamenten (18:01) Die Zukunft der Pandemie

Trainiere dein Hörverstehen mit den Nachrichten der Deutschen Welle von Freitag – als Text und als verständlich gesprochene Audio-Datei.Taifun "Rai" wütet Auf den Philippinen hat ein Wirbelsturm Verwüstungen angerichtet. Mehr als 300.000 Menschen sind auf der Flucht vor dem Taifun. Mindestens fünf Menschen kamen den Behörden zufolge ums Leben. Der Tropensturm "Rai" habe Überschwemmungen, Sturzfluten und Erdrutsche ausgelöst sowie Dächer abgedeckt und zahlreiche Bäume und Strommasten aus dem Boden gerissen, teilte der philippinische Katastrophenschutz mit. Der Schiffsverkehr ist eingestellt, zahlreiche Inlandsflüge wurden gestrichen. Mehrere Flughäfen des südostasiatischen Landes sollen schwere Schäden davongetragen haben. Viele Tote bei Bürohausbrand in Japan Nach einem Brand in einem Geschäftsgebäude in der japanischen Wirtschaftsmetropole Osaka werden der Feuerwehr zufolge zahlreiche Todesopfer befürchtet. Bei 27 von 28 Verletzten konnten keine Lebenszeichen festgestellt werden. Die Opfer seien ins Krankenhaus gebracht worden. In Japan kann nur ein Arzt einen Menschen für tot erklären. Ermittler überprüfen Informationen, denen zufolge ein Mann am Unglücksort eine Flüssigkeit aus einer Papiertüte verschüttet haben soll. Anschließend sei das Feuer im 4. Stock ausgebrochen. Auf der Etage befindet sich eine psychiatrische Klinik. EU-Gipfel stellt sich hinter die Ukraine Die europäischen Staats- und Regierungschefs haben Russland im Fall eines Angriffs auf die Ukraine mit "massiven Konsequenzen" gedroht. Eine fortgesetzte militärische Aggression würde harte Sanktionen nach sich ziehen, heißt es in einer Erklärung, die beim EU-Gipfel in Brüssel veröffentlicht wurde. Bundeskanzler Olaf Scholz hatte sich zu Beginn seines ersten regulären Gipfels hinter die Ukraine gestellt. Etwaige Sanktionen sollen eng mit Partnern wie den USA und Großbritannien abgestimmt werden. Erneut Facebook-Sicherheitsprobleme Beim Facebook-Konzern Meta sind rund 50.000 Nutzer ins Visier von Überwachungsfirmen geraten, die sie ausspionieren wollten. Die Betroffenen seien unterrichtet worden, teilte der Konzern mit. Meta, zu dem auch Instagram und Whatsapp gehören, habe mehrere Unternehmen von seiner Plattform verbannt. Die Überwachungsfirmen stammen demnach aus Israel, Indien und Nordmazedonien. Auch eine nicht näher identifizierte Gruppe aus China habe versucht, Nutzer auszuspionieren. Kritik an Johnson-&-Johnson-Impfstoff Ein US-Expertenausschuss hat empfohlen, die Corona-Impfstoffe von BioNTech/Pfizer und Moderna dem Vakzin von Johnson & Johnson vorzuziehen. Die 15 Mitglieder des bei der Gesundheitsbehörde CDC angesiedelten Beratergremiums sprachen diese Empfehlung einstimmig aus. Grund der Bedenken sind sehr selten vorkommende Blutgerinnsel in Verbindung mit einer verringerten Zahl an Blutplättchen nach einer Impfung mit dem Johnson-&-Johnson-Vakzin. Neuer Ocean-Viking-Rettungseinsatz Das Schiff der Hilfsorganisation SOS Méditerranée hat vor der Küste Libyens 114 Menschen aus dem Mittelmeer geholt. Unter den Geretteten seien 30 Minderjährige, teilte die Organisation mit. Die "Ocean Viking" wird von SOS Méditerrannée gemeinsam mit der Internationalen Föderation der Rot-Kreuz- und Roter-Halbmond-Gesellschaften betrieben. Hilfsorganisationen müssen oftmals mehrere Tage darauf warten, dass ihren Schiffen ein sicherer Hafen zugewiesen wird, in den diese einlaufen können. Ende der A380-Produktion Mit der Auslieferung der letzten A380 hat der Flugzeugbauer Airbus das Kapitel des weltweit größten Großraumfliegers beendet - nur 16 Jahre nach dem Erstflug. Die arabische Airline Emirates nahm die letzte Maschine des Typs in Hamburg in Empfang. Dann startete das Flugzeug vom Werksgelände im Stadtteil Finkenwerder zum Überführungsflug nach Dubai. Wegen der Corona-Pandemie waren keine Gäste bei der Übergabe zugegen. Die A380 übertrifft in Größe und Kapazität sogar den legendären Boeing-Jumbo 747.

Coronaimpfung für 5- bis 11-jährige Kinder (Stand 15.12.21). Heute sprechen wir über das aktuelle Top-Thema: Seit dem 09.12.2021 empfiehlt die STIKO nun offiziell eine Impfung mit dem Impfstoff von Biontech/Pfizer für 5- bis 11-jährige Kinder. Vor allem sollen solche geimpft werden die entweder selber eine schwere Vorerkrankungen haben und Kontakt zu Menschen haben, die ein erhöhtes Risiko durch Corona haben (z.B. andere vorerkrankte Kinder oder erwachsene Risikogruppen). Gerade der 3. Teil der Empfehlung, dass auch geimpft werden soll wenn die Eltern und das Kind den individuellen Wunsch hat. Viele empfinden dieses Statement als "Zurückgeben" der Verantwortung an die Erziehungsberechtigten. Bei welchen Vorerkrankungen sollten Kinder besonders dringend geimpft werden? Wie gut ist der Impfstoff überhaupt in dieser Altersklasse erforscht? Welche Nebenwirkungen können auftreten? Wie sieht die aktuelle Coronalage bei Kindern aus? Was ist eigentlich PIMS bzw. MIS-C und wie oft betrifft es Kinder? Welche relevanten Vorteile hat die Impfung aus unserer Sicht für die Altersgruppe? Diese und weitere wichtige Fragen besprechen wir in dieser Folge von Hand, Fuß, Mund!

Seit dem 13. Dezember 2021 können Eltern Kinder ab fünf Jahren in Deutschland gegen das Coronavirus impfen lassen. Laut der bisher einzigen Studie, die sich mit der Sicherheit des Impfstoffes von Biontech/Pfizer befasst, sind keine schweren Nebenwirkungen bekannt. Dennoch empfiehlt die Stiko Kinderimpfungen nur eingeschränkt - wieso?Westerhaus, Christinewww.deutschlandfunk.de, Forschung aktuellDirekter Link zur Audiodatei

As primeiras 300 mil vacinas anticovid-19 para crianças dos 5 aos 11 anos, do consórcio farmacêutico BioNTech/Pfizer, chegam a Portugal em 13 de dezembro, anunciou esta segunda-feira o secretário de Estado Adjunto e da Saúde.

Videos https://brandnewtube.com/watch/sonia-elijah-interviews-efrat-fenigson-from-israel_Ws1DDYkiqAOXdis.html     https://www.youtube.com/watch?v=GWN2PV4v0lk&t=8s   Researchers find new link between a disrupted body clock and inflammatory diseases RCSI University of Medicine and Health Sciences, November 25, 2021 New research from RCSI has demonstrated the significant role that an irregular body clock plays in driving inflammation in the body's immune cells, with implications for the most serious and prevalent diseases in humans. The circadian body clock generates 24-hour rhythms that keep humans healthy and in time with the day/night cycle. This includes regulating the rhythm of the body's own (innate) immune cells called macrophages. When these cell rhythms are disrupted (due to things like erratic eating/sleeping patterns or shift work), the cells produce molecules which drive inflammation. This can lead to chronic inflammatory diseases such as heart disease, obesity, arthritis, diabetes and cancer, and also impact our ability to fight infection. (NEXT) Social media tied to higher risk of depression Massachusetts General Hospital, November 23, 2021 The latest in a spate of studies investigating links between use of social media and depression suggests the two go hand in hand. The new study follows a yearlong look at social media use and onset of depression among nearly 5,400 adults. None reported even mild depression at the start. But in multiple surveys over 12 months, depression status had worsened in some respondents, the study found. The risk rose with use of three hugely popular social media sites: Snapchat, Facebook and TikTok. None showed any signs of depression at the first survey. But after completing at least one similar follow-up, nearly 9% showed a "significant" increase in scores for depression risk. (NEXT) Havacado or two. Study finds eating lots of the fruit has public health import Randomized controlled trial found that families with high avocado consumption self-reported reduced caloric intake and an overall healthier diet University of California at San Diego, November 29, 2021 In a novel study, researchers conducted a randomized controlled trial comparing the potential health effects between families that consumed a low allotment of avocados (three per week) and families that consumed a high allotment (14 per week) over six months. They found that the high avocado allotment families self-reported lower caloric consumption, reducing their intake of other foods, including dairy, meats and refined grains and their associated negative nutrients, such as saturated fat and sodium. (NEXT) Crabapple supplements could help cut cholesterol, China study discovers Crabapple extract has been show to lower cholesterol in obese mice which were fed a high-fat diet, researchers in China have revealed. Beijing and Shanghai universities, November 30, 2021 The study points out that statins are the major therapy for hypercholesterolaemia and for the prevention of atherosclerosis. However, there is some evidence to suggest that they may increase the risk of diabetes, muscle pain, liver damage and cause other side effects. Crabapple has long been used for the treatment of diarrhoea, indigestion and other digestive diseases in traditional Chinese medicine, and its antioxidant benefits have frequently been studied. (NEXT) Aerobic exercise preserves brain volume and improves cognitive function Wake Forest School of Medicine, November 30, 2021 Using a new MRI technique, researchers found that adults with mild cognitive impairment (MCI) who exercised four times a week over a six-month period experienced an increase in brain volume in specific, or local, areas of the brain, but adults who participated in aerobic exercise experienced greater gains than those who just stretched. (NEXT) Are you a morning or an evening person? It might be due to your gut bacteria University of Haifa (Israel), November 22, 2021 A new study by the University of Haifa reveals that certain gut bacteria differ between morning and evening people. It is already known that there are some genetic differences between larks and owls, but research in fruit flies in our laboratory inspired us to test the impact of gut bacteria on human chronotypes," says Prof. Eran Tauber. Fecal samples were collected from 91 individuals in order to extract and sequence the bacterial DNA. Analysis of the DNA sequences from each sample allowed identification of all gut bacterial species and quantify their abundance. The chronotype of the participants was determined based on their self-reported sleep times during the weekend (waking up without an alarm clock). (OTHER NEXT) Sonia Elijah interviews Efrat Fenigson from Israel Efrat Fenigson, a chief marketing officer and human rights activist from Tel Aviv, Israel, candidly speaks to Sonia about how 'Covid' has been marketed, as if it were a brand, by world governments and the mainstream media. She talks about the general protest movement in Israel and how it evolved from anti-corruption to anti-lockdown/green-pass demonstrations. She gives insight into the psychological state of fear that many Israelis are accustomed to living under making them compliant in obeying the draconian Covid rules and to not question the mass vaccine rollout. (NEXT) Foreclosure Looms for Homeowners Who Thought They'd Won, Thanks to Top New York Court Ruling Sam Mellings The City and New York Focus, November 30, 2021 Christine Fife was “speechless with joy” when she won her foreclosure case in January 2020, she recalled, believing her decade under threat of foreclosure in her Upper West Side condo was finally over. Now, though, Fife is once again facing the seizure of the apartment she has owned since 1990. In February 2021, New York's top court issued a decision that eliminated a path that New York homeowners had used for years to fight foreclosure. The decision in Freedom Mortgage Corporation v. Engel allowed Fife's lender to renew its foreclosure suit against her. “They said it was OK. How can they change their mind?” Fife asked during an interview with New York Focus and THE CITY. Across New York State, homeowners who believed that their cases had been settled in their favor are now once again facing foreclosure due to the Engel decision. Many are in danger of losing their homes, even as two bills aimed at protecting owners wend their way through the state Legislature. Case Reopened In New York, if a borrower misses a mortgage payment, the lender is allowed to demand the entire remaining balance immediately and then move to foreclose after 120 days, if the money owed remains unpaid.. But a lender must start the legal proceedings within six years of first demanding full payment, or the suit becomes invalid. Until recently, the clock kept ticking until the lender informed the borrower that they were no longer seeking foreclosure. In Fife's case, the lender had never done so. The bank sued Fife twice: first in 2010, a case the lender claims it later voluntarily withdrew, and again in 2017. Her lawyers, representing Fife pro bono, successfully argued that the bank's second foreclosure suit was barred by the six-year limit and got it dismissed. But the Engel decision changed the rules. The Court of Appeals found that voluntarily ending a foreclosure suit stops the clock on the six-year time limit — even if the homeowner is never notified. The court's ruling applies retroactively to any foreclosure cases ongoing or still open to appeal at the time the decision was issued. Following the ruling, many foreclosures that expired under the six-year limit have been reopened or appealed to higher courts. Holly Meyer, a Suffolk County lawyer who represented one of the defendants in the Engel case, estimated that the number of affected homeowners could be in the tens of thousands. Fife's was one of them. In April 2021, the bank moved to renew its foreclosure suit against her — and the trial judge cited the Engel ruling as a reason to rehear the case. “I was shocked at this decision, because I had put all my faith in [the foreclosure court's] initial decision, which was in my favor,” Fife said. With Fife's best defense gone, her hopes for avoiding foreclosure now appear slim, her legal counsel acknowledged. ‘Incompetently' Managed Loans It's not uncommon for lenders to allow their right to foreclose to expire, according to real estate lawyers. “There are millions of residential loans being serviced somewhat incompetently, so these things do sometimes slip between the cracks,” said Joshua Stein, a commercial real estate lawyer. Real estate industry supporters of the Court of Appeals' decision say it made little sense for a foreclosure case to fail because of what they consider a clerical error — one that basically lets borrowers shirk their debts. “The idea that you should still be at risk because you haven't repaid the money you borrowed doesn't strike me as egregious,” Stein said. Homeowner attorneys say that cases get dropped all the time in the legal system because of technical violations of procedural requirements, and that foreclosure cases should be no different. “If you have somebody on trial for murder, but you find that their constitutional rights were violated, they go free. It's the same thing here,” Meyer said. Chief Judge Conflicted? The day after the Court of Appeals ruled on the Engel case, the law firm Greenberg Traurig, which had represented two of the plaintiffs, cheered what it called a “ground shifting” victory for lenders. “Statewide application will likely protect billions in assets for mortgage holders,” its press release claimed. Chief Judge Janet DiFiore, who wrote the majority opinion in Engel, was a Greenberg Traurig client at the time that she ruled in favor of their bank clients in that and other cases, the New York Law Journal reported in April. The firm defended her in a suit brought by judges forced into retirement as a cost-cutting measure. Defense attorneys said they had not been informed of the potential conflict for the judge who ruled against their clients. “The law's not on our side anymore, and that means that there are a number of people who will be facing foreclosure when they wouldn't have faced it a couple of years ago,” Julie Howe, a senior staff attorney at the New York Legal Assistance Group, who is representing Fife pro bono, told New York Focus. Then-Governor Andrew Cuomo swears in Janet DiFiore as the new chief judge of the New York State Court of Appeals, Feb. 8, 2016. Governor Andrew Cuomo's Office Jacob Inwald, director of foreclosure prevention at Legal Services NYC, said many of the foreclosure cases affected by the Engel decision originally stemmed from the real estate crash of 2008 and freewheeling lending leading up to it. Fife, for instance, had borrowed $731,000 against her apartment in April 2007 to pay living expenses after a disabling injury and divorce. Monthly payments were nearly $5,000, with adjustable rate mortgage that started at 8% annual interest, potentially rising as high as 15%. “I didn't know anything about mortgages,” Fife said. “I was just so happy that I was able to live on another day. I was probably the easiest take on the block.” Within a year, the bank alleged that she had fallen behind on her mortgage payments — kicking off foreclosure proceedings that her loan's holder, Wilmington Trust Association, has resurrected more than a decade later. ‘It's Really Scary' Rockland County resident Susan Azcuy is in a situation similar to Fife's — believing that she'd survived foreclosure only to find the cloud hanging over her once again. For 23 years, Azcuy and her husband kept up with the mortgage payments on their house in Pomona, including a 2005 refinancing, for which she took on a debt of $210,000 at 5.75% interest. But in 2012, after Azcuy's husband was fired from his job, they missed a payment and their lender quickly moved to foreclose. The bank voluntarily withdrew the suit in March 2016 for technical reasons but did not notify Azcuy, refiling the case the next month. It went to trial in 2019, and Azcuy won, after a key prosecution witness failed to show up. ‘We're still struggling. I was very, very hopeful to be able to continue living here.' Before Engel, this would have been the end of the case, since more than six years had elapsed since the 2012 foreclosure suit. But thanks to Engel, the six-year clock restarted in 2016 — giving Azcuy's lender another chance to sue. Due to penalties and foreclosure fees, Azcuy now owes nearly $400,000, just shy of double the amount of the 2005 refinancing. Efforts to reach a settlement or a modification with the bank have been unsuccessful, according to Azcuy's attorney, Derek Tarson of the Legal Aid Society of Rockland County. If the bank brings another foreclosure lawsuit, which Tarson believes is likely, Azcuy will not be able to rely on the defense that more than six years have passed. “It's really scary. We're still struggling,” Azcuy said. “I was very, very hopeful to be able to continue living here.” Lawmakers Respond State lawmakers have introduced two bills seeking to reverse some of Engel's effects. One measure, sponsored by Sen. Kevin Thomas (D-Nassau) and Assemblymember Helene Weinstein (D-Brooklyn), would require lenders to inform borrowers if they withdraw their demands for payment, since that action serves to stop the clock on the six-year countdown. If lenders withdraw the lawsuit but fail to notify the borrowers, the clock would keep ticking — a return to the status quo before Engel. The bill would also forbid lenders from foreclosing if any part of the loan had previously expired — a measure that would bar reviving suits against homeowners like Fife and Azcuy. The legislature is also considering a second bill, sponsored by Sen. James Sanders (D-Queens) and Assemblymember Latrice Walker (D-Brooklyn). This bill would prevent lenders from discontinuing a demand for full payment, stopping the six-year countdown clock, without the consent of the borrower. The measure also would start the countdown from the time that a mortgage holder missed a payment. Though meant to protect homeowners, the Sanders-Walker bill could actually incentivize lenders to begin foreclosure more quickly, one foreclosure defense attorney told New York Focus. “If the clock is ticking, all plaintiffs are going to want to do is get their case started,” the attorney, who asked not to be named, said. Sanders rejected the critique. “I don't think that you can further incentivize the financial institutions” to foreclose after the leeway granted them by Engel, he said. Whether either of the bills would apply retroactively to homeowners like Fife and Azcuy is an open question. “It may not be able to help those, but it is our desire,” Sanders said. “We will get guidance on whether we can do that.” Sanders said that he has spoken to Gov. Kathy Hochul and legislative leaders about his bill, and while they have not endorsed it, he said they are open to supporting it. (A Hochul spokesperson said the governor “will review all legislation that reaches her desk.” “We are making excellent progress with both, and we expect good things in the coming days,” Sanders said. (NEXT) Israeli study says COVID shot efficacy decreases dramatically after 3 months, calls for boosters British Medical Journal, November 24, 2021 A study published by The BMJ today finds a gradual increase in the risk of COVID-19 infection from 90 days after receiving a second dose of the Pfizer-BioNTech vaccine. The study was carried out by the Research Institute of Leumit Health Services in Israel. Israel was one of the first countries to roll out a large scale COVID-19 vaccination campaign in December 2020, but which has seen a resurgence of infections since June 2021. The findings confirm that the Pfizer-BioNTech vaccine provided excellent protection in the initial weeks after vaccination, but suggest that protection wanes for some individuals with time. To do this, the researchers examined electronic health records for 80,057 adults (average age 44 years) who received a PCR test at least three weeks after their second injection, and had no evidence of previous COVID-19 infection. Of these 80,057 participants, 7,973 (9.6%) had a positive test result. These individuals were then matched to negative controls of the same age and ethnic group who were tested in the same week. The rate of positive results increased with time elapsed since a second dose. For example, across all age groups 1.3% of participants tested positive 21-89 days after a second dose, but this increased to 2.4% after 90-119 days; 4.6% after 120-149 days; 10.3% after 150-179 days; and 15.5% after 180 days or more. (NEXT) 31,014 Deaths 2,890,600 Injuries Following COVID Shots in European Database of Adverse Reactions as Young, Previously Healthy People Continue to Die Health Impact News The European Union database of suspected drug reaction reports is EudraVigilance, and they are now reporting 31,014 fatalities, and 2,890,600 injuries, following COVID-19 injections. A Health Impact News subscriber from Europe reminded us that this database maintained at EudraVigilance is only for countries in Europe who are part of the European Union (EU), which comprises 27 countries. The total number of countries in Europe is much higher, almost twice as many, numbering around 50. (There are some differences of opinion as to which countries are technically part of Europe.) Total reactions for the mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/ Pfizer: 14,526 deaths and 1,323,370 injuries to 20/11/2021 Total reactions for the mRNA vaccine mRNA-1273 (CX-024414) from Moderna: 8,518 deaths and 390,163 injuries to 20/11/2021 Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/AstraZeneca: 6,145 deaths and 1,075,335 injuries to 20/11/2021 Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 1,825 deaths and 101,732 injuries to 20/11/2021 (NEXT) Censorship = dictatorship Dr. Jessica Rose, November 29, 2021 So the censorship continues. I did a very detailed and informative interview with Frank McCaughey of Ireland on the subject of the pointlessness, potential harms and dangers with mass injecting children during this ‘pandemic' with the known non-sterilizing COVID-19 injectable products. And it has been remove Let's check out what YouTube's Community Guidelines are, shall we? YouTube's Community Guidelines: These determine what content is allowed on YouTube and help make YouTube a safe place to foster community. A safe place to foster community, eh? What kind of community are you thinkin' ‘bout there, Youtube? A community akin to an enslaved, dead-eyed mass of hypnotized automatons? If I may: no thanks on that. I'd rather live on that cat Island. So, for those of you who didn't get to see the video (I imagine that is all of you since it was up for less than 24 hours), I talked at length about the ‘don't's of injecting pre-pubescent children with experimental products for which the ingredient list is a big secret for a ‘disease' that they do not succumb to. Ah, I see now. It was because I mentioned Ivermectin. Boy. Youtube. Get with the program! Read some studies for crying out loud! And update your censorship guidelines! Make them reflect the scientific truth and not the weird false dictates of singular beings who feast on the ‘community' to increase their ‘power'. Here's what I found in their COVID-19 medical misinformation policy. Treatment misinformation: Content that encourages the use of home remedies, prayer, or rituals in place of medical treatment such as consulting a doctor or going to the hospital Content that claims that there's a guaranteed cure for COVID-19 Content that recommends use of Ivermectin or Hydroxychloroquine for the treatment of COVID-19 Claims that Hydroxychloroquine is an effective treatment for COVID-19 Categorical claims that Ivermectin is an effective treatment for COVID-19 Claims that Ivermectin and Hydroxychloroquine are safe to use in the treatment COVID-19 Other content that discourages people from consulting a medical professional or seeking medical advice Ok. I want to work backwards through the italicized points, if I may. 1. Hey Youtube. I AM a medical sciences professional. This IS my consultation. Doesn't that make your dictate of discouraging ‘consulting a medical professional' moot? I am not only not discouraging this, in addition to encouraging this, I am this. 2. Hey Youtube. GET WITH THE PROGRAM. Ivermectin has been affiliated with Nobel-ity. It's not only been awarded a prize for its safe use as an anti-parastic for decades and been doled out to literally billions of people, (including pregnant women and children) with no ill effects, it's has an excessively successful safety profile as an off-label drug in the context of COVID-19.¹ 3. It has also been clinically-tested and proven effective in the context of COVID-19 as an off-label drug - which is more than we can say about the clot shots, eh?²³⁴⁵⁶⁷⁸⁹¹⁰¹¹ 4. Based on points, 1, 2 and 3, I would recommend the off-label use of Ivermectin. As a Medical Scientist. Oh and by the way, aren't you violating your own ‘Community Standards' with your point on a ‘guaranteed cure for COVID-19'? You guys are so sure that your injections are the only way to deal with this situation. Doesn't that imply that this guarantees a cure? No wait. It doesn't. But what it does do is set a precedent and instigate a thought: there will never be a cure for COVID-19. It's incurable. Which is: true. But it's also no worse than the flu in the non-vulnerable, which is most people. Including children. So we don't need to seek a ‘cure'. Just like we don't need to seek a ‘cure' for the common cold or the flu. That's one of the things that our bloody immune systems are for and very good it - preventing disease. Viruses are EVERYWHERE. ALL THE TIME. It's not a reason to freak out. Educate yourself and others on this. It about high time people learned that we are constantly engaging and have co-evolved with viruses and bacteria for the entirety of our existences. It's what we are.¹² Our genome is 7% retrovirus. If we attempt to destroy this magnificence then we are not only stupid, but we will be destroyed in turn. Leave the immune system alone. Or rather, optimize it. Be healthy. Avoid toxins. As much as you can. Pretty simple. So there you are Youtube. You have been brought up-to-date. Now, I don't like simply bitching about stuff, even though it does feel good, so I wanted to bring it to everyone's attention that you can fight to have your content re-instated once it has been removed. However, it is not a common occurrence to have a video re-instated once it has been censored. The ones that do get re-instated typically are ones that were erroneously taken down. I think that the Youtube overlords would argue that since they are paid to enforce the dictate narrative, they cannot stand behind science and truth, and therefore, I think they would hold fast to their ‘claims' that Ivermectin is dangerous and ineffective. (NEXT) Why aren't healthcare workers speaking out about the catastrophe caused by the vaccines? Steve Kirsch, November 23, 2021 Everyone thinks that if the jabs were really dangerous, doctors and other healthcare workers would be speaking out about it. They are wrong. Here are the four main reasons they do not speak out.Two important things you need to know: 1.All the kids were recently vaccinated. 2. Kids that age NEVER get tachycardia (i.e., the medical experts I've talked to have never seen it before in their careers). Here are some reasons very few people are speaking out: 1. Delegated trust. People trust their doctors, the doctors trust other doctors and ultimately the CDC. Nobody is independently verifying the CDC is telling the truth. Doctors are really really bad in critically reading scientific studies. Mask guidelines are the PERFECT example of this. There isn't any scientific proof (well-done randomized trial) that masks work. Yet very few question the narrative (and those that do are ostracized). So everyone basically goes with the flow and the whole thing is a positive feedback loop despite zero scientific basis. See my article Masks don't work and read the accolades in the Nature article. All these experts who hailed the study never read it with a critical eye and lack the skills to do so. This is how misinformation propagates. 2.Fear of job loss. Nobody wants to lose their job. Look what happened to Deborah Conrad and others who speak out. Fired within hours after speaking out. So the lab technicians who are now seeing kids with tachycardia just keep their mouth shut. They know something is very wrong, but their job is more important. Besides, if they spoke out, it wouldn't make any difference since they are just a lab technician. Doctors have a similar problem. The medical system, despite claims of physician autonomy, actually offers very little, as it takes very little to be thrown out of the system. Medicare, the FDA, a state medical board, a malpractice insurer, the DEA, a hospital medical staff, an employer - you only have to cross one of these to have your career ruined. Combine that with the idea that most physicians wouldn't be willing to stand against a medical establishment agency such as the CDC (the ones who will have long since been ostracized) and that to do so would require a huge amount of energy and time spent on medical paper research to make a case (and most docs don't have time for that) and that most of medicine is necessarily a form of group think anyway. Then add on to it that the policy makers in large medical corporations roles are more immediately to protect the interests of the corporation than to "save the world," and you arrive at our current situation. 3.Belief that COVID is even worse than the vaccine injuries. Many people are deceived by erroneous reports that the number of vaccine cases (e.g., of myocarditis) are occurring far less often now that the vaccines have been rolled out. Dr. John Su is the big culprit here because he's never told the world that VAERS is under-reported. The pediatric cardiologists know what is going on, but they aren't going to say anything due to #1. So I see doctors tweeting the myth that “sure, there is myo after the vaccine, but the rates due to COVID are worse so the vaccine is the better of the two options.” 4.Belief that the injuries are really rare. I know a doctor who treats vaccine injured patients. He has no clue whether these are every single vaccine injured patient in the US or he's only seeing a tiny fraction of the injuries. He believes he's seeing them all so writes it off as just “coincidence” and “bad luck” since if it was the vaccine, the CDC would have spotted it. 5. Cognitive dissonance/trust in authority figures. They are so convinced the vaccines are safe (since nobody else is speaking out), that any adverse events that happen must be due to something else. Positive feedback loop. 6.Belief that they can treat you for your vaccine side effects, but that they can't treat you if you have COVID. So lesser of two evils. And of course, they think no early treatments work, so they think they are doing you a favor by telling you to get the vaccine. 7.Belief that there is no viable alternative for treating COVID and that the vaccines work. So even 100,000 dead or injured people is better than 750,000 dead people from COVID. 8. Trust in the NIH and CDC. If it was a problem, the CDC would tell people. Telling people isn't their job. Their job is to follow the direction set by the experts. 9.Fear of being ostracized. People who do research fear if they speak out they would be labelled as anti-vaxers and their research would thus be discredited. 10.Critical thinkers have been fired. Hospitals and medical facilities have already fired vaccine hesitant employees per vaccine mandates thereby self selecting for vax believers. 11. They think that the side-effects show that the vaccine is “working.” This is more of a patient thing. It's how the patients look at their adverse events… as a positive thing. (You really can't make this stuff up.) 12.They are being paid to look the other way. The federal government gave “grants” (aka BRIBES) to hospitals and physicians to promote the vaccines. If they speak out against them now, the government will demand the grants are repaid. [A physician reported this to me on Telegram. You really can't make this stuff up.] 13. They will lose their research funding if they publish their results.

Die Europäische Arzneimittelbehörde (EMA) empfiehlt Impfungen von Kindern mit dem Covid-19-Impfstoff von BioNTech/Pfizer. In Deutschland steht noch eine Empfehlung der Ständigen Impfkomission aus. STIKO-Mitglied und Kinderarzt Martin Terhardt sagte, es komme mehr auf die Impfung der Erwachsenen, als auf die der Kinder an.

A Agência Europeia de Medicamentos (EMA) vai emitir esta quinta-feira a sua decisão sobre administração da vacina anticovid-19 da BioNTech/Pfizer a crianças dos 5 aos 11 anos, podendo ser a primeira na União Europeia (UE) para esta faixa etária.

In diesen Tagen werden Patienten aus besonders betroffenen Gebieten in andere Teile Deutschlands verlegt werden. Dabei greift das sogenannte “Kleeblatt-Prinzip”. Wie es funktioniert und welche logistischen Herausforderungen damit verbunden sind, erklärt Alisa Schellenberg aus dem Gesundheitsressort von ZEIT ONLINE. Die EU-Arzneimittelbehörde (EMA) hat grünes Licht für die Zulassung des Corona-Impfstoffes von Biontech/Pfizer für Kinder von fünf bis einschließlich elf Jahren gegeben. Die Entscheidung der Ständigen Impfkommission, ob sie diese Impfung empfiehlt, wird zum Jahresende erwartet. Außerdem im Nachrichtenpodcast: Die Grünen haben ihre Ministerinnen und Minister für die Ampel-Regierung nominiert. Was noch? Hip-Hop-Beats à la Mittelalter Moderation und Produktion: Jannis Carmesin Fragen, Kritik, Anregungen? Sie erreichen uns unter wasjetzt@zeit.de. Links zur Folge: EMA: EU-Arzneimittelbehörde empfiehlt BioNTech-Zulassung für Kinder (https://www.zeit.de/gesundheit/2021-11/ema-laesst-biontech-impfstoff-fuer-fuenf-bis-elfjaehrige-zu) Corona-Impfung für Kinder: "Geimpft könnte unsere Tochter einfach wieder Kind sein" (https://www.zeit.de/zeit-magazin/leben/2021-11/corona-impfung-kinder-eltern-umfrage) Kleeblatt-Konzept für Intensivstationen: Wenn Schwerkranke durch Deutschland geflogen werden (https://www.zeit.de/gesundheit/2021-11/kleeblatt-konzept-intensivstationen-betten-covid-19-faq) Kliniken in der vierten Welle: Dramatisches Déjà-vu (https://www.zeit.de/arbeit/2021-11/kliniken-vierte-welle-intensivstation-deutschland) Was noch? Mittelalter-Eminem (https://www.youtube.com/watch?v=_fhDVVfELsM)

Gesundheitsminister Spahn verteidigt Bestellobergrenzen für den Corona-Impfstoff von BioNTech/Pfizer. Außerdem: Wie weit ist in NRW der Wiederaufbau nach der Flut?

Ulmer Eltern haben stellvertretend für viele Familien im Land einen Offenen Brief an Gesundheitsminister Lucha geschrieben. Die Ulmer Eltern fordern Lucha auf sofortige Vorbereitungen für ein Kinder-Impfangebot zu treffen. Die europäische Arzneimittelbehörde EMA will voraussichtlich schon nächste Woche über die Zulassung des Corona-Impfstoffes von Biontech-Pfizer für Kinder ab fünf Jahren entscheiden. Die Eltern fordern deshalb ein konkretes Kinder-Impfangebot über die Weihnachtsferien. Und das müsse man sofort vorbereiten. Man dürfe jetzt nicht ungenutzt Zeit verstreichen lassen. Den Offenen Brief finden Sie auf http://www.donau3fm.de

Episode 75: Multisystem Inflammatory Syndrome in Children (MIS-C).  Dr Schlaerth explains the signs, symptoms, and basic management of MIS-C. Lam explain the role of anti-obesity medications in weight management. Introduction: The Role of Drugs in Weight Loss Management    By Lam Chau, MS3, Ross University School of Medicine     Today about 70% of adult Americans are overweight or obese. Obesity is associated with increased risk of heart disease, stroke, and diabetes, among many other diseases. Studies have shown losing 5-10% of your body weight can substantially reduce your risk of cardiovascular disease.  Traditional belief is that weight loss can only be attributed to diet and exercise. While there are certainly elements of truth to that statement, medication is a safe and proven method for weight management that is often overlooked. The fact of the matter is that weight loss is an ongoing field of study with constant new research and innovations.  In June of this year, a medication named Wegovy was approved for weight loss management by the FDA. This drug is indicated for chronic weight management in patients with a BMI of 27 or greater with an accompanying weight-related ailment or in a patient with a BMI of 30 or greater. Rachel Batterham, PhD, of the Centre for Obesity Research at University College London, shared: "The findings of this study represent a major breakthrough for improving the health of people with obesity. No other drug has come close to producing this level of weight loss — this really is a game changer.” Despite breakthroughs like these, the use of medication for weight loss is still relatively low. Dr. Erin Bohula, a cardiologist and assistant professor at Harvard Medical School, believes “there are probably a few reasons for this, including cost, if not covered by insurance, and a perception these agents are not safe in light of the history with weight loss agents.” A study from 2019 examined the medical records from eight geographically dispersed healthcare organizations. They found that out of 2.2 million patients who were eligible for weight loss medication, only 1.3% filled at least 1 prescription. Weight loss is a dynamic process with many different variables. While it may not necessarily be for everyone, medication can help tremendously and is an option you should consider if you are interested in weight loss[1,2]. This is Rio Bravo qWeek, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California. Our program is affiliated with UCLA, and it's sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home.  ___________________________Multisystem Inflammatory Syndrome in Children (MIS-C).   By Katherine Schlaerth, MD, and Hector Arreaza, MD. History and epidemiologyMost children who get COVID-19 have either no symptoms or very mild symptoms. However, about 18 months ago, a new pediatric complication of COVID-19, possibly postinfectious, was described.  The eight children who were initially described had a clinical presentation which was similar to either Kawasaki Disease or perhaps toxic shock syndrome, and since these children had signs of a hyperinflammatory state coupled with shock, the new syndrome was named Multisystem Inflammatory Syndrome in Children, or MIS-C for short. By midsummer of 2021, the United States had about two thousand cases and 30 deaths in children under 21.  Other name for this condition is Pediatric Hyperinflammatory Shock. DiagnosisWhat are the criteria for a diagnosis of Multisystem Inflammatory Syndrome? They include:Age below 21Fever above 100.4 degrees Fahrenheit or 38 degrees centigrade for 24 hours (a subjective fever for more than 24 hours counts too). Laboratory evidence of inflammation which should include at least two of the following tests: elevated CRP, elevated ESR, elevated fibrinogen level, procalcitonin, D-dimer, ferritin, lactic acid dehydrogenase (LDH), interleukin-6, and neutrophil counts, low lymphocyte count and low albumin.Severe disease necessitating hospitalization with multisystem organs affected. The systems affected include cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic, and neurologic (at least three systems need to be involved). No creditable other diagnosis. Other symptoms include:GI complaints (diarrhea, vomiting, abdominal pain)Skin rashConjunctivitisHeadacheLethargyConfusionRespiratory distressSore throatMyalgiasSwollen hands/feetLymphadenopathyCardiac signs and symptoms include troponin/BNP elevation and arrhythmia. Findings on ECHO may include depressed LVEF, coronary artery abnormalities, including dilation or aneurysm, mitral regurgitation, and pericardial effusion. There also must be a positive test for SARS-CoV-2 and this test can be either a reverse transcriptase polymerase chain reaction (RT-PCR), serologic, or antigen testing. Exposure to someone who has had or is suspected of having had COVID-19 within the last 4 weeks also counts.  Patients with MIS-C may have predominately gastrointestinal symptoms, mucocutaneous findings, and may be hypotensive or “shocky” on presentation. Up to 80% require ICU admission. Thrombocytopenia and /or elevated transaminase levels can also be seen.  MIS-C vs Kawasaki DiseaseThe big issue in diagnosing MIS-C is the overlap with Kawasaki's disease and with toxic shock syndrome. Patients with Kawasaki Disease in their second week of illness often will have thrombosis, not thrombocytopenia. Whereas MIS-C usually affects school age children or adolescents, Kawasaki Disease is more commonly a problem in younger children, who have an average age of 2 years.  Kawasaki Disease is also more common in Asian children and MIS-C disproportionately seems to affect Black and Hispanic children.  Obesity seems to be another risk factor for MIS-C.  Kawasaki's Disease also has different cardiac manifestations from MIS-C. Coronary artery dilatation is common in Kawasaki's disease and left ventricular dysfunction in MIS-C, although sometimes coronary artery dilatation and rarely aneurisms can be noted on echocardiogram in putative MIS-C, which is why differentiation from Kawasaki's Disease is an issue.  PathophysiologyThe cause of MIS-C is probably postinfectious immune dysregulation. Only a minority of MIS-C patients are identified as having COVID-19 by RT-PCR, but most have positive tests for immunoglobulin G.  Statistically, there is a lag of 4-6 weeks between peak community cases of COVID-19 and the time at which children present with MIS-C.   Although research is being done on MIS-C, and theories abound about etiology, there is no clear-cut answer to why some children get MIS-C and the vast majority do not. In a review of the literature on MIS-C using literature from December 2019 through May 2020, gastrointestinal symptoms such as diarrhea, and abdominal pain were 4-5 times more common than cough and respiratory distress.  There was a slight preponderance of male patients and mean age was 8 ½ years. ICU admission was common and 2/3 required inotropic support, over ¼ needed respiratory help with extracorporeal membrane oxygenation warranted in 31 children. The death rate was 1.5 % of these very sick children treated in hospital.  In another smaller study, 80% had mild, but 44% had moderate to severe EKG abnormalities including coronary involvement. The good news was that coronary arteries were normal in all children after a month, and at 4-9 months, only 2-4% had mild heart abnormalities. Unfortunately, mechanisms of MIS-C as well as universal treatment is still being worked out. Published articles may be delayed due to time constraints in publishing. Other immunologic interventions do not have sufficient data. TreatmentWhat about the treatment of children diagnosed with MIS-C?Usually, a variety of specialists become involved initially. These can include pediatric rheumatology, infectious disease, cardiology, and hematology. If children with MIS-C meet criteria for complete or incomplete Kawasaki disease as well, regardless of COVID-19 testing results, IVIG and aspirin are reasonable.  Corticosteroid use must be individualized, and if used it may require a taper.  An echocardiogram can be done initially looking for coronary aneurisms and repeated in a week.  In severe cases, shock may be a presenting factor needing urgent attention. Generally, the treatments used are decided by the aforementioned consults and may consist of immunomodulating therapy, including possibly IVIG (2g/kg), and/or corticosteroids methylprednisolone (30mg/kg).  AntiviralsThe role of antiviral therapy is unclear and remdesivir should be reserved for children with acute COVID-19.  COVID-19 vaccination-associated myocarditisAnother entity which needs further evaluation is COVID-19 vaccination-associated myocarditis in adolescents. This problem is more common in young males and may occur after the administration of mRNA based COVID-19 vaccines. The presentation occurs within 2 weeks of COVID-19 vaccination, and clinical presentation can include chest pressure, abnormal biomarkers (elevated troponins), and cardiac imaging findings. It is unknown if subclinical cases occur.  COVID-19 infection in children, while usually benign, has the potential to become serious, and the association between some mRNA vaccines and the occurrence of myocarditis has yet to be thoroughly studied. We look forward to more and better data to guide the care of children and young adults in these spheres. The risk of having myocarditis is still higher with the actual COVID-19 than the COVID-19 vaccine. The incidence of myocarditis after BioNtech/Pfizer vaccine was 2.13 cases per 100,000 persons in a large study done in a large health care organization in Israel where more than 2 million people were vaccinated (that represents 0.00213%). Another US study showed that there were 77 cases per million doses of vaccines in young male, in contrast, there were 450 cases of myocarditis per million COVID-19 cases in the same age group.____________________________Conclusion: Now we conclude our episode number 74 “Multisystem Inflammatory Syndrome in Children.” Dr. Schlaerth explained that MIS-C is a work in progress in terms of pathophysiology, diagnosis, treatment, and prognosis. MIS-C and Kawasaki Disease are very similar, but, for example, GI symptoms, cardiac dysfunction, shock and multisystem dysfunction are more prominent in MIS-C than Kawasaki Disease. Whereas coronary artery aneurysms are more common in Kawasaki disease than MIS-C. Even without trying, every night you go to bed being a little wiser.Thanks for listening to Rio Bravo qWeek. If you have any feedback about this podcast, contact us by email RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. This podcast was created with educational purposes only. Visit your primary care physician for additional medical advice. This week we thank Hector Arreaza, Katherine Schlaerth, and Lam Chau. Audio edition: Suraj Amrutia. See you next week! _____________________References:FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014, June 04, 2021, U.S. Food and Drug Administration (FDA), https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014. Saxon DR, Iwamoto SJ, Mettenbrink CJ, et al. Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009-2015. Obesity (Silver Spring). 2019;27(12):1975-1981. doi:10.1002/oby.22581. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868321/.  Carroll, Linda, Weight-loss pills can help. So why don't more people use them? NBC News Health Care, September 2, 2018.  https://www.nbcnews.com/health/health-care/weight-loss-pills-can-help-so-why-don-t-more-n905211 World Health Organization, WHO recommends groundbreaking malaria vaccine for children at risk, October 6, 2021. https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk Lee, Min-Sheng et. al, Similarities and Differences Between COVID-19-Related Multisystem Inflammatory Syndrome in Children and Kawasaki Disease, Front. Pediatr., 18 June 2021, https://doi.org/10.3389/fped.2021.640118.  Gail F. Shust, Vijaya L. Soma, Philip Kahn and Adam J. Ratner, Pediatrics in Review July 2021, 42 (7) 399-401; DOI: https://doi.org/10.1542/pir.2020-004770. Jain SS, Steele JM, Fonseca B, et al. COVID-19 vaccination-associated myocarditis in adolescents. Pediatrics. 2021; doi:10.1542/peds.2021-053427.  https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf.  Wilson, Clare, Myocarditis is more common after covid-19 infection than vaccination,  New Scientist, 4 August 2021, https://www.newscientist.com/article/mg25133462-800-myocarditis-is-more-common-after-covid-19-infection-than-vaccination/#ixzz79JPn2E47. Son, Mary Beth F, MD, and Kevin Friedman, MD, COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis, Up to Date, September 2021, https://www.uptodate.com/contents/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis?search=kawasaki%20vs%20misc&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1  

An drei von 153 Standorten der Biontech/Pfizer-Zulassungsstudie gab es Unregelmäßigkeiten. Das berichtet eine Whistleblowerin im British Medical Journal. Experten betonen aber: Zweifel an der Sicherheit und Wirksamkeit des Impfstoffes gebe es nicht. Beides sei durch andere Studien sehr gut belegt. Von Volkart Wildermuth www.deutschlandfunk.de, Forschung aktuell Hören bis: 19.01.2038 04:14 Direkter Link zur Audiodatei

Trainiere dein Hörverstehen mit den Nachrichten der Deutschen Welle von Mittwoch – als Text und als verständlich gesprochene Audio-Datei.Republikaner Youngkin gewinnt Gouverneurswahl in Virginia Der Republikaner Glenn Youngkin hat laut Hochrechnungen der US-Fernsehsender die Gouverneurswahl im US-Bundesstaat Virginia gewonnen. Youngkin schlug demnach bei der Wahl am Dienstag mit 2,7 Prozentpunkten Vorsprung knapp seinen Rivalen Terry McAuliffe von der Demokratischen Partei. Die Gouverneurswahl galt als Stimmungstest für US-Präsident Joe Biden und seine Demokraten. Die Niederlage McAuliffes im bislang demokratisch regierten Virginia ist eine schwere Schlappe für die Demokraten. Der 64-jährige McAuliffe hatte in Umfragen lange klar vor Youngkin gelegen, zuletzt hatte Youngkin aufgeholt. USA starten Corona-Impfungen für 5-11-Jährige In den USA starten die Corona-Impfungen für Kinder im Alter zwischen fünf und elf Jahren: Nachdem die Gesundheitsbehörde CDC eine Impfempfehlung für diese Altersgruppe mit dem Vakzin von Biontech/Pfizer ausgesprochen hatte, wurden noch am selben Abend die ersten jüngeren Kinder geimpft. Präsident Joe Biden sprach von einem "Wendepunkt" im Kampf gegen die Pandemie. Die US-Arzneimittelbehörde FDA hatte dem Impfstoff Ende vergangener Woche eine Notfallzulassung für diese Altersgruppe erteilt. Die Regierung begann daraufhin bereits, weitere Impfstoffdosen ins ganze Land auszuliefern. IS bekennt sich zu Anschlag in Kabul Bei einem Angriff auf ein Militärkrankenhaus in der afghanischen Hauptstadt Kabul sind mindestens 19 Menschen getötet und 50 weitere verletzt worden. Dies teilte ein Vertreter des Gesundheitsministeriums der radikalislamischen Taliban mit, die seit August in Afghanistan an der Macht sind. Der afghanische Ableger der Dschihadisten-Miliz Islamischer Staat bekannte sich zu dem Anschlag. Nach der Machtübernahme der Taliban hat die mit ihnen verfeindete IS-Miliz bereits mehrfach Anschläge verübt. Äthiopien ruft landesweiten Ausnahmezustand aus Nach dem Vormarsch der Volksbefreiungsfront von Tigray hat Äthiopiens Zentralregierung für sechs Monate einen landesweiten Ausnahmezustand ausgerufen. Er gibt den Behörden unter anderem die Möglichkeit, Straßensperren zu errichten sowie Verkehrs- und Kommunikationsverbindungen zu unterbrechen. Auch die Übernahme der Verwaltung durch das Militär in bestimmten Bereichen ist damit möglich. Zuvor hatten die Behörden der Hauptstadt Addis Abeba die Bewohner zu den Waffen gerufen. Die Rebellen hatten zuletzt die Einnahme zweier strategisch wichtiger Städte gemeldet und mit einem Vormarsch auf die Hauptstadt gedroht. Facebook gibt Gesichtserkennungs-Funktion auf Facebook schafft die Gesichtserkennungs-Funktion ab, mit der Nutzer automatisch in Fotos markiert werden konnten. Gespeicherte Daten zur Identifizierung der Gesichter von mehr als einer Milliarde Menschen werden gelöscht, wie das Online-Netzwerk ankündigte. In der Gesellschaft gebe es Sorgen um den Einsatz von Gesichtserkenungs-Technologien - und Regulierer seien immer noch dabei, Regeln dafür zu entwickeln, hieß es zur Begründung. Facebook sehe aber weiterhin Einsatzmöglichkeiten für die Technologie etwa für die Anmeldung bei einem Account oder das Entsperren eines Geräts. Niederländer müssen wieder Masken tragen Die Niederlande haben wegen steigender Ansteckungszahlen die Corona-Maßnahmen erneut verschärft. Regierungschef Mark Rutte kündigte in Den Haag unter anderem eine Ausweitung der Maskenpflicht an. Auch der Corona-Pass wird für mehr Orte verpflichtend. Bürger sollen wieder den Sicherheitsabstand von 1,5 Meter wahren. Erst vor gut einem Monat hatte das Land viele Maßnahmen aufgehoben und etwa die 1,5 Meter-Regel abgeschafft. Daraufhin waren die Infektionszahlen schnell gestiegen. Bayern und Juve erfolgreich bei der Champions League Qualifikation Bayern München hat dank eines überragenden Robert Lewandowski frühzeitig und locker das Minimalziel Achtelfinale in der Champions League erreicht. Bei der Rückkehr des zuletzt an Corona erkrankten Trainers Julian Nagelsmann gewann der deutsche Fußball-Rekordmeister gegen Benfica Lissabon klar mit 5 : 2. Auch Juventus Turin konnte sich vorzeitig qualifizieren. Der italienische Fußball-Rekordmeister setzte sich gegen Zenit St. Petersburg mit 4 : 2 durch.

Trainiere dein Hörverstehen mit den Nachrichten der Deutschen Welle von Samstag – als Text und als verständlich gesprochene Audio-Datei.US-Impfkampagne für junge Kinder rückt näher Der Corona-Impfstoff von BioNTech/Pfizer hat in den USA eine Notfallzulassung für fünf- bis elfjährige Kinder erhalten. Das gab die amerikanische Arzneimittelbehörde FDA bekannt. "Jüngere Kinder gegen COVID-19 zu impfen, wird uns einer Rückkehr zu einer gewissen Normalität näher bringen", erklärte die geschäftsführende FDA-Chefin Janet Woodcock. Sie betonte, das Vakzin erfülle die "hohen Ansprüche" ihrer Behörde. Der Impfstoff sei auch bei Menschen unter zwölf Jahren wirksam und sicher. Die endgültige Freigabe durch die US-Gesundheitsbehörde CDC wird kommende Woche erwartet. G20-Gipfeltreffen beginnt in Italiens Hauptstadt Die Staats- und Regierungschefs der führenden Industrie- und Schwellenländer kommen in Rom zu einem zweitägigen Gipfel zusammen. Thematisch sollen an diesem Samstag die Corona-Pandemie und die Lage der Weltwirtschaft im Mittelpunkt stehen. Die Arbeitssitzungen am Sonntag sind dann den Themen Klimaschutz und Entwicklungspolitik gewidmet. Es ist das erste Präsenztreffen der G20-Spitzen seit mehr als zwei Jahren. Deutschland wird von der geschäftsführenden Bundeskanzlerin Angela Merkel und ihrem wahrscheinlichen Nachfolger Olaf Scholz vertreten. Biden und Macron legen U-Boot-Streit bei US-Präsident Joe Biden und Frankreichs Staatschef Emmanuel Macron haben sich bei ihrem Treffen vor Beginn des G20-Gipfels um eine Beilegung des U-Boot-Konflikts bemüht. Die Art und Weise, wie das neue Sicherheitsbündnis mit Australien und Großbritannien eingefädelt worden sei, sei "ungeschickt" gewesen, sagte Biden in Rom. Frankreich war im Vorfeld nicht informiert worden und hatte einen milliardenschweren Rüstungsauftrag verloren. Der US-Präsident betonte, Frankreich sei ein extrem wertvoller Partner. Macron sagte, es gehe nun darum, eine noch stärkere Zusammenarbeit mit den USA zu schaffen. Polens Parlament für befestigte Grenzanlage zu Belarus Das polnische Parlament hat grünes Licht für den Bau einer umstrittenen befestigten Grenzanlage zu Belarus gegeben. Die nationalkonservative Regierung reagiert mit dem rund 353 Millionen Euro teuren Vorhaben auf den gestiegenen Andrang von Flüchtlingen. Die Grenzbarriere soll sich über mehr als 100 Kilometer entlang der östlichen EU-Außengrenze erstrecken. Seit August haben tausende Menschen - meist aus dem Nahen Osten und Afrika - versucht, die polnische Grenze von Belarus aus zu überqueren. Warschau hat dort bereits Tausende Soldaten stationiert und einen Stacheldrahtzaun errichtet. Guterres fordert Zurückhaltung von Sudans Militär UN-Generalsekretär Antonio Guterres hat an die neuen Machthaber im Sudan appelliert, die für diesen Samstag angekündigte Großdemonstration gegen den Militärputsch zuzulassen. Die Armee solle sich zurückhalten, damit es nicht noch mehr Opfer gebe, erklärte Guterres. In dem nordostafrikanischen Land hatte General Abdel Fattah al-Burhan am Montag die Entmachtung der zivilen Regierungsmitglieder und einen Ausnahmezustand verkündet. Bei Zusammenstößen zwischen Sicherheitskräften und Demonstranten gab es bereits mehrere Tote und zahlreiche Verletzte, wie Augenzeugen berichteten. Briten sorgen sich um Gesundheitszustand der Queen Die britische Königin Elizabeth II. wird auf Anraten ihrer Ärzte noch "mindestens zwei Wochen" lang eine Ruhepause einlegen. Die 95-Jährige werde lediglich "leichte Aufgaben" wie etwa Videoschalten wahrnehmen, teilte der Buckingham-Palast mit. Die britische Monarchin hatte sich in der vergangenen Woche nach Palastangaben zu "vorsorglichen Untersuchungen" in ein Londoner Privatkrankenhaus begeben und dort eine Nacht verbracht. Die Eröffnungsrede des am Sonntag in Schottland beginnenden UN-Klimagipfels wird statt der Queen Thronfolger Prinz Charles halten. Airbus testet nachhaltigen Treibstoff auf Pflanzenöl-Basis Der europäische Flugzeugbauer Airbus hat eine Testreihe mit nachhaltig hergestelltem Kerosin gestartet. Nach Angaben des Unternehmens flog eine Maschine des Typs A319neo drei Stunden lang ausschließlich mit sogenanntem Sustainable Air Fuel (SAF) im Tank über dem Firmensitz in Toulouse. Der Treibstoff wurde hauptsächlich aus altem Speiseöl hergestellt. Die Versuche sollen bis Mitte 2023 fortgesetzt werden. Neben Flugzeugen sollen im kommenden Jahr auch Helikopter des Typs Airbus H160 mit alternativen Treibstoffen getestet werden. Glossar

Autor: Sarre, Claudia Sendung: Informationen am Morgen Hören bis: 19.01.2038 04:14

Autor: Sarre, Claudia Sendung: Das war der Tag Hören bis: 19.01.2038 04:14

Moçambique: Alexandre Chivale nega envolvimento em alegados crimes no caso das Dívidas Ocultas. Portugal: Jovem guineense apresenta queixa contra empresa por racismo. Covid-19: África prepara-se para produzir vacinas da Moderna e BioNTech/Pfizer.

The UK's medicines regulator has approved the BioNTech/Pfizer vaccine against COVID-19 for emergency use, the companies said today. The UK is the first country to approve the vaccine for widespread use — paving the way for some of the most “high risk” citizens, such as elderly care home residents, to get the jab before the end […]